Thursday, April 9, 2020

Fw: (LML) WHO, ILEP and Global Partnership for Zero Leprosy guidelines for persons affected by leprosy in times of COVID-19

 

Leprosy Mailing List – April 9,  2020

 

Ref.:    (LML) WHO, ILEP and Global Partnership for Zero Leprosy guidelines for persons affected by leprosy in times of COVID-19

                                                                                                          

From:  Wim van Brakel, Amsterdam, the Netherlands


(Note Editor: Yesterday, the accompanying text with the two annexes by Wim van Brakel were lost in transmission. On his request we sent herewith his original text. Our excuses for the misunderstanding. The two annexes with the recommendations from ILEP, WHO and GPZL you received already.)

 

Dear Pieter,

ILEP, WHO and GPZL have now also issued recommendations on the management of different aspects of leprosy services in the context of Covid. Spanish and Portuguese versions are also being produced.


Wim van Brakel

Medical Director




P.O. Box 95005, 1090 HA Amsterdam, The Netherlands
www.nlrinternational.org   |  Twitter: @NLR_NoLeprosy

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/4d0b1f8f-7c81-4fef-b772-598d8cef63ba%40googlegroups.com.

Wednesday, April 8, 2020

Fw: (LML) WHO, ILEP and Zero Leprosy guidelines for persons affected by leprosy in times of COVID-19

 

Leprosy Mailing List – April 8,  2020

 

Ref.:    (LML) WHO, ILEP and Zero Leprosy guidelines for persons affected by leprosy in times of COVID-19

 

From:  Wim van Brakel, Amsterdam, the Netherlands


Dear Pieter,

The
WHO, ILEP and Zero Leprosy released joined guidelines for persons affected by leprosy in times of COVID-19. These guidelines, like the Brazilian guidelines, may be of interest to national leprosy control programmes and leprosy-related NGOs, as examples and a stimulus to develop locally adapted guidelines.


Best,

Wim van Brakel




P.O. Box 95005, 1090 HA Amsterdam, The Netherlands
www.nlrinternational.org   |  Twitter: @NLR_NoLeprosy


Annexes:

-          Advice about leprosy and COVID-19

-          Conseils sur la lèpre et le COVID-19


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/166a9d47-755e-418c-8c41-a7584e312d84%40googlegroups.com.

Fw: (LML) Brazilian guidelines for persons affected by leprosy in times of COVID-19

 

Leprosy Mailing List – April 8,  2020


Ref.:    (LML) Brazilian guidelines for persons affected by leprosy in times of COVID-19


From:  Henk Eggens, Santa Comba Dão, Portugal


Dear Pieter,

The Brazilian Leprology Society released guidelines for persons affected by leprosy in times of COVID-19 on April 4 2020. I think these Brazilian guidelines may be of interest to national leprosy control programmes and leprosy-related NGOs in other countries, as an example and a stimulus to develop locally adapted guidelines.

I annex the original text in Portuguese and my translation in English .

Best,

Henk Eggens


Annexes:
Orientações da SBH para pessoas atingidas pela hanseníase durante pandemia COVID-19.pdf
Guidelines For People Affected By Leprosy During The Covid-19 Pandemic-SBH-2020-04-04.docx

---
Henk Eggens

(henk.eggens@gmail.com)


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/59375dcf-8b8e-4377-b015-27975178ebcf%40googlegroups.com.

Tuesday, April 7, 2020

Fw: (LML) Loss of alms income during coronavirus crisis

 

Leprosy Mailing List – April 7,  2020


Ref.:  (LML)   Loss of alms income during coronavirus crisis


From:  Joel Almeida, London and Mumbai


Dear Pieter,

 

The biggest challenge for people who normally survive on alms giving is mere survival, during coronavirus-related lockdowns. Without special attention to people disfigured by HD, we can expect deaths not just from coronavirus but eventually also from starvation.

 

If we step into the shoes of someone with no digits, experiencing a sudden shutdown in alms giving, we can begin to appreciate how they are struggling to survive. Even people without disfigurement struggle to fight their way to the front of the queue for bare necessities. People with physical disabilities have very slim prospects.

 

All friends of those affected might consider raising their voices to encourage governments to take special measures to provide at least survival rations to HD-affected people previously dependent on alms for survival. We would like, of course, that nobody should be dependent on alms, but we have to deal with reality as it is today. Even organisations in the UN family can do the needful to help protect HD-affected people during this crisis.

 

Joel Almeida


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/677ab640-13fe-487b-b4b2-073a64474843%40googlegroups.com.

Saturday, April 4, 2020

Fw: (LML) View COVID-19 research, resources, and information

Visit our COVID-19 collection and sign up for updates
View this email in your browser
PLOS
A Message to Our Community Regarding COVID-19

PLOS is committed to accelerating publication and disseminating research as quickly and openly as possible to support researchers, public health officials, and citizens around the world in their work to slow the spread of COVID-19.

We’re working on a number of initiatives to help our community find the COVID-19 research they need, in the way they want to receive it. Here’s how you can stay informed:
 

View Resources: COVID-19 Collection

Our Open Access collection highlights a range of work across all PLOS journals, including:

• Research articles

• Blog posts

• PLOS channels

Get Updates: COVID-19 Research Alerts

To help you keep up to date with the new research being published, we’ve created a dedicated COVID-19 Research Alert. Sign up to receive regular updates by email with links to newly published COVID-19 research articles.

For further COVID-19 research links and resources visit the Copyright Clearance Center.

We’re here to help our community in these uncertain times. If you need more information or further resources at any time, visit and bookmark our COVID-19 page for updates. Please do not hesitate to get in touch with us directly via email, or through social media.

Twitter Facebook Email
To discontinue email communications from PLOS, you can unsubscribe.
Update Profile   Terms of Use   Privacy Policy
PLOS
Public Library of Science
1160 Battery St. Suite 225, San Francisco, CA 94111, US
 

Leprosy Mailing List – April 4,  2020


Ref.:   (LML) View COVID-19 research, resources, and information


From:  PLOS journals and Academia, San Francisco, USA



Dear colleagues,

 

We received from PLOS Journals and ACADEMIA the following information regarding updates on the COVID-19 pandemic.

 

Best wishes in these difficult times,

 

Pieter AM Schreuder

Editor LML

 

PLOS Journals

 

 

PLOS is committed to accelerating publication and disseminating research as quickly and openly as possible to support researchers, public health officials, and citizens around the world in their work to slow the spread of COVID-19.

We're working on a number of initiatives to help our community find the COVID-19 research they need, in the way they want to receive it. Here's how you can stay informed:


View Resources: COVID-19 Collection

Our Open Access collection highlights a range of work across all PLOS journals, including:

 Research articles

 Blog posts

 PLOS channels


Get Updates: COVID-19 Research Alerts

To help you keep up to date with the new research being published, we've created a dedicated COVID-19 Research Alert. Sign up to receive regular updates by email with links to newly published COVID-19 research articles.



For further COVID-19 research links and resources visit the Copyright Clearance Center.

We're here to help our community in these uncertain times. If you need more information or further resources at any time, visit and bookmark our COVID-19 page for updates. Please do not hesitate to get in touch with us directly via email, or through social media.

 

Public Library of Science

San Francisco, USA

 

 



 



 

Dear Academia Community,

Academia has members and visitors from all around the world. Wherever you are right now, we are wishing you well. We hope this letter finds you in a place of safety and health. Our thoughts are with those of you who may be unwell, anxious, or grieving during this time.

We wanted to share an update about what is going on with Academia and Coronavirus. First of all, mercifully, the team is all healthy here. There's a shelter-in-place order for San Francisco and the Bay Area, so we are all working from home. That's going well so far - we are able to keep everything running, and the team is working at full strength.

Academia's mission is to Accelerate the World's Research. We feel that mission is particularly pertinent at this time. Our platform is able to provide access and distribution at a very large scale, so that's what we will do with Coronavirus and COVID-19 research.

We have put together a page highlighting some key research papers on the novel coronavirus and the COVID-19 disease. You can find it here. In addition to curated content, it also lists the related reading that our algorithms have found for those papers.

As always, we appreciate your help in creating and sharing this work. If you know of a paper that should be featured, please email us at coronavirus@academia.edu.

If you have written a related paper that you want to get out to the community, please upload it to your profile at academia.edu/Papers/Upload, and then let us know about it via the email address above.

Finally, we've made our Premium features free for Coronavirus- and COVID-19-related content. Advanced Search, Bulk Download, 5-minute Overviews, and Lists are available without a Premium account for all relevant searches and papers.

We are grateful for the important work that scientists, doctors, nurses, teachers, parents, and all others are doing at this time. Thank you from all of us here - we are proud you are our community. We'll continue to work on our mission and wish you well over the next weeks and months. Please let us know if you have any thoughts about what else we can do to help.

 

Our best wishes to you all, and take care,

 

Richard, Ben, Mitch, and the whole Academia team

San Francisco, USA


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 










 

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/fc6ad1a2-c2ab-4c13-9f49-9212b7914c87%40googlegroups.com.

Fw: (LML) Infolep monthly overview of new publications on leprosy, April 2020

 

 

Leprosy Mailing List – April 4,  2020


Ref.:  (LML)   Infolep monthly overview of new publications on leprosy, April 2020

From:  Jisje Erlings, Amsterdam, the Netherlands


Dear Pieter and colleagues,

 

We trust that you are coping and managing in different ways in the present global Covid pandemic.

Like every month we send you an overview of (scientific) publications on leprosy recently added to the Infolep website. To search the full collection, please visit www.leprosy-information.org.

Lots of information resources are currently being developed related to leprosy, disability, inclusion, and COVID-19. Infolep has developed a key topic page on Leprosy and COVID-19. This is still a work in progress. I would appreciate receiving additional material. 

Wishing you the best in the present situation, stay safe and keep well.

Jiske Erlings

Infolep Coordinator
www.leprosy-information.org
j.erlings@leprastichting.nl
 


 

 


 

Highlighted publication

 


 


COVID-19: WHO issues interim guidance for implementation of NTD programmes
Read more on the WHO website

Orientações aos médicos da Sociedade Brasileira de Hansenologia (SBH) sobre a  possibilidade de coinfecção Hanseníase  e- COVID-19  / Guidelines for doctors of the Brazilian Society of Hansen's disease (SBH) on the possibility of coinfection Leprosy and COVID-19. 
Available from the Infolep Key topic page on Leprosy and COVID-19

The WHO Bulletin - April 2020. Special theme: 
Artificial intelligence in the health sector.
Read online

 


 

New publications

 


 

The use of personal protective equipment by nurses during consultations with leprosy patients. 
Castro et al. International Journal of Advanced Engineering Research and Science. 2020; 7 (3) : 390-394.
Download PDF

Biologics in leprosy: A systematic review and case report.
Cogen AL, Lebas E, De Barros B, et al. Am J Trop Med Hyg. 2020.
Read more

Orthopedic surgical foot management in Hansen disease.
Cohen JC, de Miranda ST. Orthop Clin North Am. 2020 Apr;51(2):279-291.
Read more

Why we should stop using the word leprosy.
Deps P, Cruz A. Lancet Infect Dis. 2020 Mar 2. pii: S1473-3099(20)30061-X.
Read more

Prevalence of Mycobacterium leprae in armadillos in Brazil: A systematic review and meta-analysis.
Deps PD, Antunes JM, Santos AR, Collin SM. PLoS Negl Trop Dis. 2020;14(3):e0008127.
Download PDF

Chronic unilateral uveitis as a manifestation of leprosy: A case report and literature review.
Duran Merino CE, Ortiz Úsuga MC, Jaramillo MJ, Rodríguez AM. Ocul Immunol Inflamm. 2020;1–5.
Read more

Development of LepReact, a defined skin test for paucibacillary leprosy and low-level M. leprae infection.
Duthie MS, Pena MT, Khandhar AP, et al. Appl Microbiol Biotechnol. 2020;10.
Read more

Perfil epidemiológico da hanseníase no período de 2015 a 2018 no município de Goianésia (GO) Perfil epidemiológico da hanseníase em Goianésia, Goiás / Epidemiological profile of leprosy in the period from 2015 to 2018 in the city of Goianésia (GO) Epidemiological profile of leprosy in Goianésia, Goiás.
Espíndola M. Brazilian journal of health review. 2020;
Download PDF

Análise do perfil epidemiológico das formas de apresentação da hanseníase no estado de Goiás / Analysis of the epidemiological profile of the forms of presentation of leprosy in the state of Goiás.
Garbelini G, Paiva I, Filho P. Brazilian journal of health review. 2020; 3 (2) : 2525-2530.
Download PDF

Skin disease in the tropics and the lessons that can be learned from leprosy and other neglected diseases.
Hay RJ. Acta Derm Venereol. 2020
Read abstract

Central Latin America: Two decades of challenges in neglected tropical disease control. 
Hotez PJ, Damania A, Bottazzi ME. PLoS Negl Trop Dis. 2020;14(3):e0007962. . 
Download PDF

Studi Epidemiologi Hubungan Status Ekonomi Daerah Terhadap Insidensi dan Prevalensi Lepra di Wilayah Jawa Timur.
Ichmalia A, Herlina S, Triliana R. Jurnal bio komplementer medicine. 2020.
Download PDF

T cell responses to mycobacterial glycolipids: On the spectrum of "innateness".
James CA, Seshadri C. Front Immunol. 2020 Feb 11;11:170.
Download PDF

Risk factor for Mycobacterium leprae detection in household contacts with leprosy patients: a study in Papua, East Indonesia.
Krismawati H, Oktavian A, Maladan Y, et al. Medical Journal of Indonesia. Faculty of Medicine, Universitas Indonesia. 2020; 29 (1) : 64-70.
Download PDF

Altered composition and functional profile of high-density lipoprotein in leprosy patients.
Lemes RMR, Silva CAME, Marques MÂM, et al. PLoS Negl Trop Dis. 2020;14(3):e0008138.
Download PDF

The principle of non-discrimination and non-stigmatization: reflections on leprosy
Levantezi, M, Shimizu H E , Garrafa V. Revista Bioetica. 2020.
Download PDF

Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms.
Lima MIS, Capparelli FE, Dias Oliveira JD, et al. Front. Microbiol. 11:429.
Download PDF 

Brief outcome of five decades of battle with infectious diseases in Iran. 
Lohrasbi, V., Mohammadzadeh, N. & Shirmohammadlou, N. VirusDis. 31, 10–12 (2020).
Read abstract

Delay in leprosy diagnosis.
Marfatia Y, Surani A, Shah D. Indian journal of leprosy. 2020; 92 (1) : 19-29.
Download PDF

Leprosy: clinical aspects and diagnostic techniques.
Maymone MBC, Laughter M, Venkatesh S, et al. J Am Acad Dermatol. 2020.
https://www.jaad.org/article/S0190-9622(20)30474-6/pdf

Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae.
Mendes ALG, Joaquim HDM, Zamae MIS, et al. Mem Inst Oswaldo Cruz. 2020 Feb 27;115:e190324.
Download PDF

Demographics of new diagnoses of leprosy in the UK over 23 years: a retrospective study of cases at the Hospital for Tropical Diseases, London.
McIntosh A, Checkley A, McBride A, et al. Access Microbiology. Microbiology Society. 2020;
Download PDF

Fluorescent hybridization of Mycobacterium leprae in skin samples collected in Burkina Faso.
Millogo A, Loukil A, Fellag M, et al. J Clin Microbiol. 2020 Mar 4.
Read more 

A challenging case of domestically acquired leprosy in the Southern United States
Mohan S, Fairley JK. Open Forum Infect Dis. 2020;7(3):ofaa060.
Download PDF

Machine learning approaches in drug development of leprosy.
Moin S, Jain A. Studies in Indian place names. 2020.
Download PDF

The impact of leprosy, podoconiosis and lymphatic filariasis on family quality of life: A qualitative study in Northwest Ethiopia.
van 't Noordende AT, Aycheh MW, Schippers A. PLoS Negl Trop Dis. 2020 Mar 10;14(3):e0008173.
Download PDF

A call to action for universal health coverage: Why we need to address gender inequities in the neglected tropical diseases community. 
Ozano K, Dean L, Yoshimura M, et al.PLoS Negl Trop Dis. 2020;14(3):e0007786.  
Download PDF

Global leprosy status in 2020: Still losing touch. 
Paredes CF, Montes de Oca Sanchez G, White C. Ann Acad Med Singapore. 2020;49(1):1–2.
Download PDF 

Tuberculoid leprosy with external jugular vein thrombosis: A case report and literature review.
Rahil AI, Osman A, Magdi M, et al. Eur J Case Rep Intern Med. 2020 Jan 20;7(2):001302. 
Download PDF

The immunology of other mycobacteria: M. ulcerans, M. leprae. 
Röltgen K, Pluschke G, Spencer JS, Brennan PJ, Avanzi C. Semin Immunopathol. 2020.

Analysis of clinical aspects of leprosy patients between 2010-2017 at a reference center in Campinas.
Santos MASD, Aquino JLB, Pegas E, Machado ECFA. An Bras Dermatol. 2020 Feb 12.
Download PDF

Leprosy stigma & the relevance of emergent therapeutic options.
Sardana K, Khurana A. Indian J Med Res. 2020 Jan;151(1):1-5.
Download PDF

A estigmatização da Hanseníase: Vivências dos pacientes tratados em uma unidade básica de saúde / The stigmatization of Leprosy: Experiences of patients treated in a health center.
Silva W. Brazilian journal of development. 2020.
Download PDF

Breve historico da hanseníase: Diagnóstico e tratamento.
da Silva K, de Oliveira E, Morais F, et al. Ações de Saúde e Geração de Conhecimento nas Ciências Médicas 3. Atena Editora. 2020. 
Download PDF

Hanseníase e carência social: definição de áreas prioritárias em estado endêmico do Nordeste brasileiro / Leprosy and social deprivation: Definition of priority areas in an endemic state Northeastern Brazil.
Souza CDF, Magalhães MAFM, Luna CF. Rev Bras Epidemiol.  2020 Feb 21;23:e200007.
Download PDF

Low performance of operational indicators for leprosy control in the state of Bahia: spatiotemporal patterns, 2001-2014. Baixo desempenho de indicadores operacionais de controle da hanseníase no estado da Bahia: padrões espaçotemporais, 2001-2014. 
Souza EA, Heukelbach J, Oliveira MLW, et al. Rev Bras Epidemiol. 2020;23:e200019. 
Download PDF

Incidence and clinical spectrum of leprosy in a tertiary care centre in Jharkhand: A retrospective study.
Suman S, Chaudhary S, Kumar R, et al. Journal of dental and medical sciences. 2020.
Download PDF

Leprosy reactions: Earlier diagnosis leads to more effective treatment. 
Thangaraju P, Venkatesan S. Rev Soc Bras Med Trop. 2020;53:e20190375. 
Download PDF

Distribuição espacial das doenças tropicais negligenciadas na região des oeste do Estado de São Paulo. 
Titosse A, Fonseca E, Rodrigues M, et al. Caminhos de Geografia. 
Download PDF

Importance of epidemiological surveillance of leprosy: analysis of the occurrence of leprosy in intra-domiciliary contacts in a capital in the Brazilian northeast region. 
Trindade LC, Martins LC, Marques DM, et a. Rev Soc Bras Med Trop. 2020;53:e20190507. 
Download PDF

Leprosy and anaesthesia : Peri-operative concerns in patients with Hansen's disease.
Uma H, Bharti D, Singhal S. Indian journal of leprosy. 2020; 92 (1) : 39-47.
Download PDF

Adding MASP1 to the lectin pathway-Leprosy association puzzle: Hints from gene polymorphisms and protein levels. 
Weinschutz Mendes H, Boldt AW, Stahlke E, et al. PLoS Negl Trop Dis. 2020;14(4):e0007534.
Download PDF

'Zero Leprosy' and other endgame strategies: Rhetoric vs. realism in public health campaigns.
White C. Glob Public Health. 2020;1–12.
Read abstract
 

 


 

 


 



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/e9e2f8be-cb6a-47c3-bc96-ae72543f3a24%40googlegroups.com.